| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |